PBYIPuma Biotechnology, Inc.
$9.98+93% 1Y
$9.98
$4.7352 weeks$9.98
Latest close: a new 52-week highOct 8, 2026what changed →Oct 4, 2024$2.42 – $9.98 · dashed line: 200-day averageOct 8, 2026
What is the market doing?
Good
1 good, 2 without dataIn an uptrend. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendUptrendderived · Oct 8, 2026
In an uptrend, above its rising 50- and 200-day averages. Price is +32% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PBYI is trading
Puma Biotechnology, Inc. is +93% over the past year while the S&P 500 is +18%: 74 points ahead of the market.
+93%
1-year return · S&P 500 +18%
- vs 200-day average
- +32%
vs 200-day average · a clear uptrend
- RSI (14)
- 57
RSI (14) · neutral
- Below its 52-week high
- 0.00%
Below its 52-week high
Details›
- Last close2026-10-08
- $9.98
- 1 monthS&P 500 +1.6%
- +10%
- 1 yearS&P 500 +18%
- +93%
- 5 yearsS&P 500 +86%
- +42%
- vs 50-day average$9.18
- +8.7%
- 52-week high
- $9.98
- 52-week low
- $4.73
- Annualised volatility
- 67%
| Year | Return |
|---|---|
| 2026 (year to date) | +68% |
| 2025 | +95% |
| 2024 | −30% |
| 2023 | +2.4% |
| 2022 | +39% |
| 2021 | −70% |
| 2020 | +17% |
| 2019 | −57% |
| 2018 | −79% |
| 2017 | +222% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +0.92% |
| Feb | 10 | 4 of 10 | +6.0% |
| Mar | 10 | 5 of 10 | +0.63% |
| Apr | 10 | 5 of 10 | −0.46% |
| May | 10 | 5 of 10 | +0.79% |
| Jun | 10 | 7 of 10 | +5.6% |
| Jul | 11 | 5 of 11 | +1.7% |
| Aug | 11 | 6 of 11 | +5.2% |
| Sep | 11 | 7 of 11 | +1.4% |
| Oct | 11 | 3 of 11 | −13% |
| Nov | 10 | 6 of 10 | +18% |
| Dec | 10 | 2 of 10 | −5.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.